EmTech Biotechnology Development, Inc., the biotech incubator jointly operated by Emory University and the Georgia Institute of Technology, has announced its seed grant funding for 2005-2006. The seed grant program, supported by contributions from both institutions, funds one-year projects at Emory, Georgia Tech, or joint projects involving both. Emphasis is on research with the potential for tangible commercial applications.
Newly funded projects include the following:
Development of a small molecule drug against CXCR4 for the inhibition of cancer metastasis
Hyun Suk Shim, PhD
Assistant Professor, Winship Cancer Institute, Emory University School of Medicine
Development of calpain inhibitors for treatment of peripheral neuropathy
Jonathan Glass, associate professor of neurology, Emory University School of Medicine
James C. Powers, PhD., Regents Professor of Chemistry, Georgia Institute of Technology
TransThermal drug delivery
Mark Prausnitz, PhD, associate professor of chemical and biomolecular engineering
Mark Allen, Ph.D., Joseph M. Pettit Professor of Electrical and Computer Engineering
Georgia Institute of Technology
Delivery of alpha-1 antitrypsin transgene as potential treatment for chronic obstructive pulmonary disease
Mauricio Rojas, assistant professor of medicine, Emory University School of Medicine
For more information about the EmTech Bio Seed Grant Program, contact Connie Snipes (email@example.com, 404-727-4518).